Skip to main content
SpringerLink
Log in

Diabetic Neuropathy

  • Chapter
  • First Online:
Diabetes and Peripheral Vascular Disease

Part of the book series: Contemporary Diabetes ((CDI))

Abstract

Diabetic neuropathy is the most common peripheral neuropathy in the Western world. It is a chronic and devastating complication of diabetes mellitus (DM) that leads to significant morbidity and impact on quality of life of patients. Diabetic peripheral neuropathy (DPN) is the most frequent neurological complication of DM; in fact at least 50% of diabetic subjects have DPN. Autonomic neuropathy may affect systems like the cardiovascular, metabolic, gastrointestinal, genitourinary, and the peripheral. The presentation of diabetic neuropathy can profoundly vary based on which nerves and which class of fibers are affected. In this chapter we describe the clinical presentation, the pathogenesis, and the possible treatments available for the management of diabetic neuropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Urbancic-Rovan V. Causes of diabetic foot lesions. Lancet. 2005;366(9498):1675–6.

    Article  PubMed  Google Scholar 

  2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782–7.

    Article  PubMed  CAS  Google Scholar 

  3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.

    Article  PubMed  Google Scholar 

  4. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817–24.

    Article  PubMed  CAS  Google Scholar 

  5. Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2000;16 Suppl 1:S84–92.

    Article  PubMed  Google Scholar 

  6. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med. 1995;122(8):561–8.

    Google Scholar 

  7. Saouaf R, Arora S, Smakowski P, Caballero AE, Veves A. Reactive hyperemic response of the brachial artery: comparison of proximal and distal occlusion. Acad Radiol. 1998;5(8):556–60.

    Article  PubMed  CAS  Google Scholar 

  8. Eriksson KF, Nilsson H, Lindgarde F, et al. Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabet Med. 1994;11(3):279–85.

    Article  PubMed  CAS  Google Scholar 

  9. Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am J Epidemiol. 1990;131(4):633–43.

    PubMed  CAS  Google Scholar 

  10. Singh JP, Larson MG, O’Donnell CJ, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000;86(3):309–12.

    Article  PubMed  CAS  Google Scholar 

  11. Greene DA, Winegrad AI. In vitro studies of the substrates for energy production and the effects of insulin on glucose utilization in the neural components of peripheral nerve. Diabetes. 1979;28(10):878–87.

    Article  PubMed  CAS  Google Scholar 

  12. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813–20.

    Article  PubMed  CAS  Google Scholar 

  13. Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001;44(11):1973–88.

    Article  PubMed  CAS  Google Scholar 

  14. Wada R, Yagihashi S. Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann N Y Acad Sci. 2005;1043:598–604.

    Article  PubMed  CAS  Google Scholar 

  15. Makita Z, Radoff S, Rayfield EJ, et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med. 1991;325(12):836–42.

    Article  PubMed  CAS  Google Scholar 

  16. Meerwaldt R, Links TP, Graaff R, et al. Increased accumulation of skin advanced glycation end-­products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia. 2005;48(8):1637–44.

    Article  PubMed  CAS  Google Scholar 

  17. Garay-Sevilla ME, Regalado JC, Malacara JM, et al. Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with type 2 diabetes mellitus. J Endocrinol Invest. 2005;28(3):223–30.

    PubMed  CAS  Google Scholar 

  18. Misur I, Zarkovic K, Barada A, Batelja L, Milicevic Z, Turk Z. Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy. Acta Diabetol. 2004;41(4):158–66.

    Article  PubMed  CAS  Google Scholar 

  19. Van Dam PS, Van Asbeck BS, Erkelens DW, Marx JJ, Gispen WH, Bravenboer B. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab Rev. 1995;11(3):181–92.

    Article  PubMed  Google Scholar 

  20. Low PA, Lagerlund TD, McManis PG. Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int Rev Neurobiol. 1989;31:355–438.

    Article  PubMed  CAS  Google Scholar 

  21. Ohara Y, Sayegh HS, Yamin JJ, Harrison DG. Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. Hypertension. 1995;25(3):415–20.

    Article  PubMed  CAS  Google Scholar 

  22. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA. Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res. 2002;90(1):107–11.

    Article  PubMed  CAS  Google Scholar 

  23. Beckman JA, Goldfine AB, Goldin A, Prsic A, Kim S, Creager MA. Inhibition of protein kinase Cbeta does not improve endothelial function in type 2 diabetes. J Clin Endocrinol Metab. 2010;95(8):3783–7.

    Article  PubMed  CAS  Google Scholar 

  24. Mehta NN, Sheetz M, Price K, et al. Selective PKC beta inhibition with ruboxistaurin and endothelial function in type-2 diabetes mellitus. Cardiovasc Drugs Ther. 2009;23(1):17–24.

    Article  PubMed  CAS  Google Scholar 

  25. Watkins PJ, Edmonds ME. Clinical features of diabetic neuropathy. In: Pickup J, Williams G, editors. Textbook of diabetes, vol. 2. Oxford: Blackwell; 1997. p. 50.51–20.

    Google Scholar 

  26. Bruyn GW, Garland H. Neuropathies of endocrine origin. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology, vol. 8. Amsterdam: North Holland Publishing; 1970. p. 29.

    Google Scholar 

  27. Low PA, Suarez GA. Diabetic neuropathies. Baillieres Clin Neurol. 1995;4(3):401–25.

    PubMed  CAS  Google Scholar 

  28. Bird SJ, Brown MJ. The clinical spectrum of diabetic neuropathy. Semin Neurol. 1996;16(2):115–22.

    Article  PubMed  CAS  Google Scholar 

  29. Garland H. Diabetic amyotrophy. Br Med J. 1955;2(4951):1287–90.

    Article  PubMed  CAS  Google Scholar 

  30. Coppack SW, Watkins PJ. The natural history of diabetic femoral neuropathy. Q J Med. 1991;79(288):307–13.

    PubMed  CAS  Google Scholar 

  31. Clayburgh RH, Beckenbaugh RD, Dobyns JH. Carpal tunnel release in patients with diffuse peripheral neuropathy. J Hand Surg [Am]. 1987;12(3):380–3.

    CAS  Google Scholar 

  32. Sharma KR, Cross J, Farronay O, Ayyar DR, Shebert RT, Bradley WG. Demyelinating neuropathy in diabetes mellitus. Arch Neurol. 2002;59(5):758–65.

    Article  PubMed  Google Scholar 

  33. Koller H, Kieseier BC, Jander S, Hartung HP. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med. 2005;352(13):1343–56.

    Article  PubMed  Google Scholar 

  34. Watkins PJ. Diabetic autonomic neuropathy. N Engl J Med. 1990;322(15):1078–9.

    Article  PubMed  CAS  Google Scholar 

  35. Burgos LG, Ebert TJ, Asiddao C, et al. Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology. 1989;70(4):591–7.

    Article  PubMed  CAS  Google Scholar 

  36. Hilsted J, Parving HH, Christensen NJ, Benn J, Galbo H. Hemodynamics in diabetic orthostatic hypotension. J Clin Invest. 1981;68(6):1427–34.

    Article  PubMed  CAS  Google Scholar 

  37. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161(16):1989–96.

    Article  PubMed  CAS  Google Scholar 

  38. Horowitz M, Jones KL, Rayner CK, Read NW. ‘Gastric’ hypoglycaemia – an important concept in diabetes management. Neurogastroenterol Motil. 2006;18(6):405–7.

    Article  PubMed  CAS  Google Scholar 

  39. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med. 2009;6(5):1232–47.

    Article  PubMed  Google Scholar 

  40. Gazzaruso C, Giordanetti S, De Amici E, et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation. 2004;110(1):22–6.

    Article  PubMed  Google Scholar 

  41. Bhasin S, Enzlin P, Coviello A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369(9561):597–611.

    Article  PubMed  CAS  Google Scholar 

  42. Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakoumopoulou E, Katsilambros N. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med. 2009;26(3):302–5.

    Article  PubMed  CAS  Google Scholar 

  43. Restivo DA, Lanza S, Patti F, et al. Improvement of diabetic autonomic gustatory sweating by botulinum toxin type A. Neurology. 2002;59(12):1971–3.

    Article  PubMed  CAS  Google Scholar 

  44. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology. 1999;53(9):1937–42.

    Article  PubMed  CAS  Google Scholar 

  45. Gasparini L, Netzer WJ, Greengard P, Xu H. Does insulin dysfunction play a role in Alzheimer’s disease? Trends Pharmacol Sci. 2002;23(6):288–93.

    Article  PubMed  CAS  Google Scholar 

  46. Caselli A, Rich J, Hanane T, Uccioli L, Veves A. Role of C-nociceptive fibers in the nerve axon reflex-related vasodilation in diabetes. Neurology. 2003;60(2):297–300.

    Article  PubMed  CAS  Google Scholar 

  47. Hernandez C, Burgos R, Canton A, Garcia-Arumi J, Segura RM, Simo R. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study. Diabetes Care. 2001;24(3):516–21.

    Article  PubMed  CAS  Google Scholar 

  48. Rizza RA, Cryer PE, Gerich JE. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. J Clin Invest. 1979;64(1):62–71.

    Article  PubMed  CAS  Google Scholar 

  49. Meyer C, Grossmann R, Mitrakou A, et al. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients. Diabetes Care. 1998;21(11):1960–6.

    Article  PubMed  CAS  Google Scholar 

  50. Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med. 1987;316(22):1376–83.

    Article  PubMed  CAS  Google Scholar 

  51. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol. 1980;8(6):590–6.

    Article  PubMed  CAS  Google Scholar 

  52. Dyck PJ, Karnes J, O’Brien PC, Swanson CJ. Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology. 1986;36(10):1300–8.

    Article  PubMed  CAS  Google Scholar 

  53. Young RJ, Zhou YQ, Rodriguez E, Prescott RJ, Ewing DJ, Clarke BF. Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes. 1986;35(2):192–7.

    Article  PubMed  CAS  Google Scholar 

  54. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27(6):1458–86.

    Article  PubMed  Google Scholar 

  55. Bril V, Perkins BA. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care. 2002;25(11):2048–52.

    Article  PubMed  Google Scholar 

  56. Vinik AI, Newlon P, Milicevic Z, et al. Diabetic neuropathies: an overview of clinical aspects. In: LeRoith D, Taylor SI, Olefsky JM, editors. Diabetes mellitus: a fundamental and clinical text. Philadelphia: Lippincot-Raven; 1996.

    Google Scholar 

  57. Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry. 1983;46(6):491–9.

    Article  PubMed  CAS  Google Scholar 

  58. Oyibo SO, Prasad YD, Jackson NJ, Jude EB, Boulton AJ. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med. 2002;19(10):870–3.

    Article  PubMed  CAS  Google Scholar 

  59. New drug for neuropathic pain. FDA Consum. 2004;38(6):2.

    Google Scholar 

  60. Jensen TS. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain. 2002;6(Suppl A):61–8.

    Article  PubMed  CAS  Google Scholar 

  61. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50(6):1842–6.

    Article  PubMed  CAS  Google Scholar 

  62. Thisted RA, Klaff L, Schwartz SL, et al. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study. Clin Ther. 2006;28(10):1607–18.

    Article  PubMed  CAS  Google Scholar 

  63. Jarvis B, Coukell AJ. Mexiletine. A review of its therapeutic use in painful diabetic neuropathy. Drugs. 1998;56(4):691–707.

    Article  PubMed  CAS  Google Scholar 

  64. Yuen KC, Baker NR, Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diabetes Care. 2002;25(10):1699–703.

    Article  PubMed  CAS  Google Scholar 

  65. Rayman G, Baker NR, Krishnan ST. Glyceryl trinitrate patches as an alternative to isosorbide dinitrate spray in the treatment of chronic painful diabetic neuropathy. Diabetes Care. 2003;26(9):2697–8.

    Article  PubMed  Google Scholar 

  66. Chalk C, Benstead TJ, Moore F. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Database Syst Rev. 2007;(4):CD004572.

    Google Scholar 

  67. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 1995;38(12):1425–33.

    Article  PubMed  CAS  Google Scholar 

  68. Yamagishi S, Uehara K, Otsuki S, Yagihashi S. Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice. J Neurochem. 2003;87(2):497–507.

    Article  PubMed  CAS  Google Scholar 

  69. Vinik AI, Bril V, Kempler P, et al. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clin Ther. 2005;27(8):1164–80.

    Article  PubMed  CAS  Google Scholar 

  70. Schratzberger P, Walter DH, Rittig K, et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest. 2001;107(9):1083–92.

    Article  PubMed  CAS  Google Scholar 

  71. Hughes RA, Dalakas MC, Cornblath DR, Latov N, Weksler ME, Relkin N. Clinical applications of intravenous immunoglobulins in neurology. Clin Exp Immunol. 2009;158 Suppl 1:34–42.

    Article  PubMed  CAS  Google Scholar 

  72. Srinivasan S, Stevens M, Wiley JW. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes. 2000;49(11):1932–8.

    Article  PubMed  CAS  Google Scholar 

  73. Apfel SC, Kessler JA. Neurotrophic factors in the therapy of peripheral neuropathy. Baillieres Clin Neurol. 1995;4(3):593–606.

    PubMed  CAS  Google Scholar 

  74. Apfel SC, Kessler JA, Adornato BT, Litchy WJ, Sanders C, Rask CA. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology. 1998;51(3):695–702.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Microcirculation Lab, Joslin Beth Israel Deaconess Foot Center, Harvard Medical School, 1 Deaconess Rd., Boston, MA, 02215, USA

    Francesco Tecilazich M.D & Aristidis Veves M.D., M.Sc., D.Sc.

  2. Division of Podiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

    Thanh L. Dinh D.P.M.

Authors
  1. Francesco Tecilazich M.D
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thanh L. Dinh D.P.M.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aristidis Veves M.D., M.Sc., D.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aristidis Veves M.D., M.Sc., D.Sc. .

Editor information

Editors and Affiliations

  1. Columbia University College of Physician, Division of Vascular Surgery, New York Presbyterian Hospital, 72 East 93rd Street, Apt 2 AB, New York, 10128, New York, USA

    Gautam V. Shrikhande

  2. Columbia University College of Physician, Division of Vascular Surgery, New York Presbyterian Hospital, 161 Fort Washington Ave. Suite 535, New York, 10032, New York, USA

    James F. McKinsey

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Tecilazich, F., Dinh, T.L., Veves, A. (2012). Diabetic Neuropathy. In: Shrikhande, G., McKinsey, J. (eds) Diabetes and Peripheral Vascular Disease. Contemporary Diabetes. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-158-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-158-5_4

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-157-8

  • Online ISBN: 978-1-62703-158-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation